# Quest PharmaTech Inc. — Form D

Quest PharmaTech Inc. of EDMONTON, A0, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-29. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2015-10-29
- Form: D
- Accession: 0001477932-15-006675
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.5M
- Minimum investment: $1.5M
- Investors: 1
- Date of first sale: 2015-10-13
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-250328

## Issuer

- Name: Quest PharmaTech Inc.
- CIK: 0001657074
- Entity type: Corporation
- Jurisdiction: ALBERTA, CANADA
- Address: 8123 ROPER ROAD NW, EDMONTON, A0, T6E 6S4
- Phone: 1(780)448-1400

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Bin Huang | Director | Richmond, A1 |
| Ragupathy Madiyalakan | Director | Edmonton, A0 |
| Ian McConnan | Director | Edmonton, A0 |
| Lorne Meikle | Director | Toronto, A6 |
| Paul Van Damme | Director | Toronto, A6 |
| Madi Madiyalakan | Executive Officer | Edmonton, A0 |
| Pierre Vermette | Executive Officer | Edmonton, A0 |
| Thomas Woo | Executive Officer | Edmonton, A0 |

## More

- [CIK 1657074 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1657074&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001477932-15-006675.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.